Alfred Zippelius

32PUBLICATIONS
234CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity.

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|May 29, 2026
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

|Mar 19, 2026
Proteasome-guided haem signalling axis contributes to T cell exhaustion.

Yingxi Xu, Yangtao Shangguan, Yu-Ming Chuang

|Feb 09, 2026
Cell Therapies and Bispecific Engagers: Redefining Strategies against Checkpoint Resistance.

Heinz Läubli, David König, Marco Donia

|Nov 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.

Anaïs Perrichet, Julie Lecuelle, Emeric Limagne

Pageof 6

Frequent Collaborators

12 joint publications

Heinz Laubli

10 joint publications

Marcel Trefny

5 joint publications

Priska Auf der Maur

5 joint publications

Marina Natoli